Press release
Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data | Report by Fact.MR
To remain ‘ahead’ of your competitors, request for a sample @
https://www.factmr.com/connectus/sample?flag=S&rep_id=2268
Carbapenem-resistant Enterobacteriaceae Testing Market: Segmentation
Based on test type, the global Carbapenem-resistant Enterobacteriaceae Testing Market is segmented as:
Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing
Minimal inhibitory concentration Carbapenem-resistant Enterobacteriaceae Testing
Other types of Carbapenem-resistant Enterobacteriaceae Testing
Based on end users, the global Carbapenem-resistant Enterobacteriaceae Testing Market is segmented as:
Hospitals
Ambulatory Surgical Centers
Intensive Care Units
Clinics
Nursing Homes
Long Term Acute Care Centers
Others
Based on geography, the global Carbapenem-resistant Enterobacteriaceae Testing Market is segmented as:
North America
Latin America
Europe
CIS & Russia
Japan
APEJ
Middle East & Africa
Carbapenem-resistant Enterobacteriaceae Testing
Market: Overview
In Carbapenem-resistant Enterobacteriaceae Testing, Modified Hodge tests are anticipated to be one of the leading test types for Carbapenem-resistant enterobacteriaceae testing because of high accuracy of test results. These tests are easy to perform and can be performed in a routine laboratory, which makes them more feasible and thus, one of the leading test types in Carbapenem-resistant enterobacteriaceae testing market. Molecular testing detects the resistance mechanism whereas phenotypic tests detect the in-vitro activity of carbapenemase enzyme. Healthcare settings, such as nursing homes and acute care centers, where constant medical care is required for a longer duration of time are more prone to CRE and thus, the demand for Carbapenem-resistant enterobacteriaceae testing is higher in these settings.
Request Full Report With TOC@
https://www.factmr.com/connectus/sample?flag=T&rep_id=2268
Carbapenem-resistant Enterobacteriaceae Testing Market: Key Players
Some of major participants operating in the Carbapenem-resistant Enterobacteriaceae Testing market are TBA, SolGent Co., Ltd., ELITechGroup, ALIFAX S.r.l. and bioMérieux, Inc.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Request Customized Report As Per Your Requirements@
https://www.factmr.com/connectus/sample?flag=RC&rep_id=2268
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight:https://www.factmr.com/report/2268/carbapenem-resistant-enterobacteriaceae-testing-market
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data | Report by Fact.MR here
News-ID: 2255830 • Views: …
More Releases from Fact.MR
Organic Rice Syrup Market is forecasted to increase at a CAGR of 5.1% and US$ 1. …
The global Organic Rice Syrup Market is projected to expand steadily over the coming decade, driven by rising consumer demand for natural, clean-label sweeteners and growing awareness of health and wellness trends. Industry analysts estimate that the organic rice syrup market, valued at approximately USD 450 million in 2025, is expected to reach nearly USD 880 million by 2035, registering a compound annual growth rate (CAGR) of about 7.1% during…
Compound Horse Feedstuff Market is Estimated to Grow at a CAGR of 4.6%, Reaching …
The global compound horse feedstuff market is galloping toward steady growth, projected to expand from a valuation of USD 3.8 billion in 2026 to approximately USD 5.4 billion by 2036. This represents a compound annual growth rate (CAGR) of 3.6% over the ten-year forecast period.
The market is being driven by the "humanization" of equine companions, the professionalization of equestrian sports, and a significant shift toward specialized performance nutrition that…
Nutritional Yeast Market Forecasted CAGR is 7.1% by 2035 | Fact.MR Report
The global nutritional yeast market is experiencing a significant surge in demand, projected to grow from a valuation of USD 515.2 million in 2026 to approximately USD 1.2 billion by 2036. This represents a robust compound annual growth rate (CAGR) of 8.8% over the ten-year forecast period.
The market is being propelled by the global explosion of plant-based diets and the "clean-label" movement, with nutritional yeast emerging as the primary…
Dairy Stabilizer Market is Expected to Reach USD 1,420.0 million by 2035 | Resea …
The global Dairy Stabilizers Market is projected to sustain solid growth over the next decade as consumer demand for high-quality dairy and dairy-based products continues to expand across foodservice and retail sectors. Industry analysts estimate that the dairy stabilizers market, valued at approximately USD 2.4 billion in 2025, is expected to reach around USD 4.3 billion by 2035, registering a compound annual growth rate (CAGR) of about 6.5% during the…
More Releases for Enterobacter
HABP/VABP Market Size in the 7MM is projected to grow a significant CAGR by 2034 …
DelveInsight's "Hospital-acquired and Ventilator-associated Bacterial Pneumonia Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Hospital-acquired and Ventilator-associated Bacterial Pneumonia, historical and forecasted epidemiology as well as the HABP/VABP market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Discover Key Insights into the Hospital-acquired and Ventilator-associated Bacterial Pneumonia Market with DelveInsight's In-Depth Report @ https://www.delveinsight.com/sample-request/hospital-acquired-and-ventilator-associated-bacterial-pneumonia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways…
Klebsiella Infections Pipeline Insight 2025: Innovative Antibiotics and Novel Th …
DelveInsight's "Klebsiella Infections - Pipeline Insight, 2025" explores the evolving landscape of therapies aimed at tackling Klebsiella pneumoniae and related species, which are major culprits behind hospital-acquired infections, including pneumonia, bloodstream infections, and urinary tract infections. The rise of multidrug-resistant (MDR) and carbapenem-resistant strains has made Klebsiella a critical public health challenge with high morbidity and mortality.
The pipeline is advancing with novel β-lactam/β-lactamase inhibitor combinations, next-generation aminoglycosides, siderophore cephalosporins, and…
Multidrug-Resistant Gram-Negative Infections Pipeline Insight, 2025: Tackling Es …
DelveInsight's "Multidrug-Resistant Gram-Negative Infections - Pipeline Insight, 2025" report delivers an in-depth analysis of the dynamic R&D landscape targeting MDRGN pathogens such as Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, and Enterobacter species. The report covers over 10 promising investigational therapies in various stages of development, including β-lactam/β-lactamase inhibitor combinations, novel tetracyclines, polymyxins, and non-traditional antibacterial agents.
As antimicrobial resistance surges globally, pharma and biotech innovators are shifting focus toward new mechanisms…
Hospital-acquired and Ventilator-associated Bacterial Pneumonia Treatment Market …
DelveInsight's "Hospital-acquired and Ventilator-associated Bacterial Pneumonia Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Hospital-acquired and Ventilator-associated Bacterial Pneumonia, historical and forecasted epidemiology as well as the HABP/VABP market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Discover Key Insights into the Hospital-acquired and Ventilator-associated Bacterial Pneumonia Market with DelveInsight's In-Depth Report @ Hospital-acquired and Ventilator-associated…
Klebsiella Infections Pipeline: 7+ Companies Targeting Multi-Drug Resistance wit …
With rising concerns over antibiotic-resistant Klebsiella strains, more than 7 companies are actively developing cutting-edge therapies, including Nosopharm, Debiopharm, and Locus Biosciences. The Klebsiella infections pipeline spans novel antibiotics, monoclonal antibodies, bacteriophage therapy, and immunotherapies. Efforts are particularly focused on carbapenem-resistant Klebsiella pneumoniae (CRKP), an urgent threat per WHO. The pipeline reflects a crucial shift toward precision antimicrobials and host-directed therapies to overcome resistance and reduce mortality in nosocomial infections.
DelveInsight's…
Hospital-acquired and Ventilator-associated Bacterial Pneumonia Treatment Market …
DelveInsight's "Hospital-acquired and Ventilator-associated Bacterial Pneumonia Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Hospital-acquired and Ventilator-associated Bacterial Pneumonia, historical and forecasted epidemiology as well as the HABP/VABP market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Discover Key Insights into the Hospital-acquired and Ventilator-associated Bacterial Pneumonia Market with DelveInsight's In-Depth Report @ Hospital-acquired and Ventilator-associated…
